Somatic treatments There has been growing interest in the potential application of vagus nerve stimulation (VNS) in the nonpharmacological treatment of TRD.47-43 In July 2005, the US Food and Drug Administration approved VNS with an indication for the adjunctive long-term treatment of chronic or recurrent, depression for adults refractory to antidepressant drugs (with the recommendation that. patients have failed at least, four traditional therapies before using VNS). Similarly, repetitive transcranial

magnetic stimulation (rTMS) has been studied as an adjunctive treatment for drug-resistant MDD.54-56 However, results so far have been conflicting, a fact #Ca-ATPase pump keyword# that may be related to variability in stimulation parameters and small sample sizes, as well as heterogeneity of concomitant drug treatments. Larger trials are ongoing. Other novel neurostimulation

Inhibitors,research,lifescience,medical treatments with preliminary evidence of efficacy for TRD include deep brain stimulation57,58 and magnetic seizure therapy.59,60 There remains controversy within the field in terms of the efficacy and safety of electroconvulsive therapy (ECT) as a treatment modality. Following a meta-analysis, a group of researchers in the United Kingdom recently found that ECT is an effective short-term treatment for depression, with some evidence suggesting that ECT is more effective Inhibitors,research,lifescience,medical than pharmacotherapy61 However, in a recent study, another group looked at ECT versus pharmacotherapy as a treatment for relapse prevention, finding that both treatments had limited efficacy with more than half of patients experiencing relapse

or dropping out of the study.62 Psychotherapy Inhibitors,research,lifescience,medical Cognitive, interpersonal, and behavioral psychotherapy have all been shown to be effective in the treatment of depression, with results comparable to those found with antidepressant Inhibitors,research,lifescience,medical medications in randomized controlled trials.63-65 Specifically, cognitive behavioral therapy (CBT) appears to reduce residual symptoms in depression and Edoxaban ultimately reduces the risk of relapse.66-69 It has also been suggested that combined treatment with antidepressant medication and psychotherapy may be more effective than either strategy alone.70,71 However, others caution that the advantage of combined treatment, may be limited to treatment of patients with more complex depressive disorders, including characteristics such as comorbidity, chronicity, treatment resistance, episodicity, and severity.72 Strategies to sustain remission Disease self-management There is evidence that patient-focused interventions rather than purely disease-focused interventions have a more sustainable impact, on outcomes. Disease self management is predicated on promoting patient self-management and physician adherence to guidelines.